Brand Asset Management Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Brand Asset Management Group’s Portfolio CNCR Stock Details CNCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-973	Closed	-$29K	–	102
2021 Q1	$29K	Hold	973	–	–	0.01%	171
2020 Q4	$31K	Hold	973	–	–	0.02%	150
2020 Q3	$27K	Hold	973	–	–	0.02%	158
2020 Q2	$26K	Hold	973	–	–	0.02%	158
2020 Q1	$19K	Hold	973	–	–	0.01%	170
2019 Q4	$23K	Hold	973	–	–	0.01%	185
2019 Q3	$18K	Hold	973	–	–	0.01%	194
2019 Q2	$21K	Hold	973	–	–	0.01%	195
2019 Q1	$20K	Buy	+973	New	+$20.4K	0.01%	179
2018 Q4	–	Sell	-1,000	Closed	-$25K	–	234
2018 Q3	$25K	Hold	1,000	–	–	0.02%	164
2018 Q2	$24K	Buy	+1,000	New	+$27K	0.02%	170

Other funds holding CNCR

BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LWPC

Legacy Wealth Partners (California) Calabasas, California $180M AUM 48.85% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Brand Asset Management Group's CNCR Position: Q2 2021 in Review

Brand Asset Management Group sold out of ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) in Q2 2021, closing a stake of 973 shares — an estimated $29K sold.

Brand Asset Management Group first reported a position in CNCR in Q2 2018 and held it in 11 quarters. The position peaked at $31K in Q4 2020. 21 funds tracked by Wall St. Rank hold CNCR as of Q2 2021.

Brand Asset Management Group reported no remaining ETF Series Solutions Trust Range Cancer Therapeutics ETF position as of Q2 2021 after selling out during the quarter.
Brand Asset Management Group sold 973 ETF Series Solutions Trust Range Cancer Therapeutics ETF shares in Q2 2021, an estimated $29K.
Brand Asset Management Group first reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q2 2018 and held it in 11 quarters.
Brand Asset Management Group's ETF Series Solutions Trust Range Cancer Therapeutics ETF position peaked at $31K in Q4 2020.
21 funds tracked by Wall St. Rank held ETF Series Solutions Trust Range Cancer Therapeutics ETF as of Q2 2021.

Based on Brand Asset Management Group's 13F filing for Q2 2021, filed 9 Aug 2021.